MéthylPlus

- Methylating agents and cofactors
- Reduces dangerous levels of homocysteine
- Reduces the risk of cardiovascular diseases
- Prevents damage to blood vessels
- Slows down the aging process
Methylation is a key process essential for the proper functioning of all cells in the body and helps prevent aging and disease. Methylation reduces homocysteine, a toxic amino acid that significantly increases the risk of heart disease, cancer, bone loss, joint breakdown, mood imbalance and cognitive decline.
MethylPlus contains all cofactors and methyl donors required in methylation processes and for the conversion of homocysteine ​​into useful amino acids: vitamin B6, vitamin B12, folate and trimethylglycine (TMG). This combination of nutrients has been shown to significantly reduce homocysteine ​​levels after just 6 weeks of supplementation. TMG alone can reduce plasma homocysteine ​​levels by up to 30%. Additionally, B vitamins, particularly B6, B12, and folate, have been shown to reduce the risk of stroke due to their ability to reduce homocysteine.
It was recently discovered that a large portion of the population has a mutation in the MTHFR gene that prevents it from converting folate into its usable form, L-5-MTHF. This results in folate deficiency and decreased methylation leading to elevated homocysteine ​​levels. The folate used in MethylPlus is in the form of L-5-MTHF, making it an ideal supplement for people with the MTHFR mutation.
The vast majority of people do not get the specific nutrients that promote methylation from their diet. MethylPlus is an excellent supplement for aging in general, for people with high homocysteine ​​levels and for those looking for support against degenerative diseases of bones, joints, nerves and cognitive functions related to aging.
AOR's MethylPlus formula combines the maximum number of cofactors and methyl donors needed to convert homocysteine ​​into useful amino acids, helping to reduce the risk of heart disease.